GSK plc
Search results
Vaccines Help Protect Us. Every year, vaccination saves up to 5 million lives around the world. But an additional 1.5 million lives could be saved with improved vaccination coverage. 1. Why vaccines matter. Our Vaccines at a Glance. 500 million +. people vaccinated annually with our vaccines worldwide. 1.3 million.
The Sanofi–GSK COVID‑19 vaccine is a recombinant protein subunit vaccine containing the SARS-CoV-2 spike protein, which is produced in insect cells via a baculovirus vector. It also includes an adjuvant made by GSK.
Apr 17, 2023 · The Sanofi vaccine, known as VidPrevtyn Beta, is protein-based and instead contains copies of the SARS-CoV-2 spike protein from the beta variant. This variant was first detected in South Africa and was classified as a variant of concern in December 2020.
Jun 24, 2005 · Sanofi-GSK’s vaccine is the first candidate to demonstrate efficacy in a placebo-controlled trial in an environment of high Omicron variant circulation. The vaccine candidate showed a favorable safety and tolerability profile.
May 17, 2005 · PARIS and LONDON – May 17, 2021 – The Sanofi and GSK adjuvanted recombinant COVID-19 vaccine candidate achieved strong rates of neutralizing antibody responses, in line with those measured in people who have recovered from COVID-19, in all adult age groups in a Phase 2 study with 722 volunteers.
Jun 24, 2022 · Sanofi and GlaxoSmithKline have reported promising results from trials of their Covid-19 vaccine, which has proved to be particularly effective against the Omicron strain of coronavirus.
May 17, 2021 · Sanofi, the French pharmaceutical company, said on Monday that it would move the experimental Covid-19 vaccine it is developing with GlaxoSmithKline into a late-stage trial after the shot...
